Description     Claims     Drawing  

WO2015038665A1   [0048] 
US20120128636A1   [0048] 
WO2014210037A   [0048] 
US20150104428A1   [0048] 
US20130330300A1   [0048] 
US20140154220A1   [0048] 

Cellular Therapy Products   [0002] 
Mesenchymal stem cells in health and disease   [0003] 
Immunomodulatory properties of mesenchymal stromal cells   [0003] 
Human mesenchymal stem cells modulate allogeneic immune cell responses   [0003] 
Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study   [0006] 
Mesenchymal stem cell transplantation reverses multiorgan dysfunction in systemic lupus erythematosus mice and humans   [0006] 
Mesenchymal-stem-cell-induced immunoregulation involves FAS-ligand-/FAS-mediated T cell apoptosis   [0006] 
Stem Cell Research & Therapy   [0007] 
Journal of Translational Medicine   [0007] 
Stem Cells in Dentistry - Part I: Stem Cell Sources   [0048] 
Mesenchymal stem cells inhibit multiple myeloma cells via the Fas/Fas ligand pathway   [0048]